References
- European Monitoring Centre for Drugs and Drug Addiction. Medical use of cannabis and cannabinoids: questions and answers for policymaking. Luxembourg: Publications Office of the European Union; 2018 [displayed 22 March 2019]. Available at http://www.emcdda.europa.eu/publications/rapid-communications/medical-use-of-cannabis-and-cannabinoids-questions-and-answers-for-policymaking_en
- Congressional Research Service. Report R44742. Defining Hemp: A Fact Sheet [displayed 22 March 2019]. Available at https://crsreports.congress.gov
- Zuardi AW. History of cannabis as a medicine: A review. Rev Bras Psiquiatr 2006;28:153–7. doi: 10.1590/S1516-44462006000200015
- Abuhasira R, Shbiro L, Landschaft Y. Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America. Eur J Intern Med 2018;49:2–6. doi: 10.1016/j.ejim.2018.01.001
- Grinspoon L, Bakalar J. Marihuana: The Forbidden Medicine. New Haven: Yale University Press; 1997.
- Di Marzo V. New approaches and challenges to targeting the endocannabinoid system. Nat Rev Drug Discov 2018;17:623–39. doi: 10.1038/nrd.2018.115
- Ferjan I, Kržan M, Lipnik-Štangelj M, Žiberna L, Stanovnik L, Černe K. Farmakologija kanabinoidov. Zdrav Vestn 2015;84:456–71 [displayed 22 March 2019]. Available at https://www.dlib.si/stream/URN:NBN:SI:DOC-KYQQTGWH/08a52892-59b7-40b8-9da3-6a9b38f289d8/PDF
- Fine PG, Rosenfeld MJ. The endocannabinoid system, cannabinoids, and pain. Rambam Maimonides Med J 2013;4(4):e0022. doi: 10.5041/RMMJ.10129
- Andre CM, Hausman JF, Guerriero G. Cannabis sativa: The plant of the thousand and one molecules. Front Plant Sci 2016;7:19. doi: 10.3389/fpls.2016.00019
- Panlilio LV, Goldberg SR, Justinova Z. Cannabinoid abuse and addiction: Clinical and preclinical findings. Clin Pharmacol Ther 2015;97:616–27. doi: 10.1002/cpt.118
- Mulalić E, Sollner Dolenc M. Synthetic cannabinoids. In: Drev A, editor. Report on the drug situation 2015 of the Republic of Slovenia. Ljubljana: Inštitut za varovanje zdravja; 2015. p. 21–2 [displayed 22 March 2019]. Available at http://www.nijz.si/sites/www.nijz.si/files/publikacije-datoteke/nr_2015_f.pdf
- Sutlović D, Prkačin I, Vaiano F, Bertol E, Veršić Bratinčević M, Definis-Gojanović M. A case of synthetic cannabinoid poisoning in Croatia. Arh Hig Rada Toksikol 2018;69:186–90. doi: 10.2478/aiht-2018-69-3100
- Vučinić S, Kilibarda V, Đorđević S, Đorđević D, Perković Vukčević N, Vuković-Ercegović G, Antonijević B, Ćurčić M, Antonijević E, Brajković G. Clinical and analytical experience of the National Poison Control Centre with synthetic cannabinoids. Arh Hig Rada Toksikol 2018;69:178– 85. doi: 10.2478/aiht-2018-69-3096
- European Monitoring Centre for Drugs and Drug Addiction. Cannabis legislation in Europe: an overview. Luxembourg: Publications Office of the European Union; 2018 [displayed 22 March 2019]. Available at http://www.emcdda.europa.eu/publications/adhoc/cannabis-legislation-europe_en
- United Nations Office on Drugs and Crime (UNODC). Single Convention on Narcotic Drugs, 1961 [displayed 22 March 2019]. Available at https://www.unodc.org/unodc/en/treaties/single-convention.html
- Danenberg E, Sorge L, Wieniawski W, Elliott S, Amato L, Scholten W. Modernizing methodology for the WHO assessment of substances for the international drug control conventions. Drug Alcohol Depend 2013;131:175–81. doi: 10.1016/j.drugalcdep.2013.02.032
- United Nations Office on Drugs and Crime (UNODC). Convention on Psychotropic Substances, 1971 [displayed 22 March 2019]. Available at https://www.unodc.org/unodc/en/treaties/psychotropics.html
- United Nations Office on Drugs and Crime (UNODC). United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988 [displayed 22 March 2019]. Available at https://www.unodc.org/unodc/en/treaties/illicit-trafficking.html
- Aizpurua-Olaizola O, Elezgarai I, Rico-Barrio I, Zarandona I, Etxebarria N, Usobiaga A. Targeting the endocannabinoid system: future therapeutic strategies. Drug Discovery Today 2017;22:105–10. doi: 10.1016/j.drudis.2016.08.005
- National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington (DC): The National Academies Press; 2017. doi: 10.17226/24625
- Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use [displayed 22 March 2019]. Available at https://eur-lex.europa.eu/eli/dir/2001/83/oj
- European Medicines Agency. Orphan designation: Cannabidiol for: the treatment of Dravet syndrome [displayed 22 March 2019]. Available at https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3141339
- European Medicines Agency. Epidyolex. EPAR [displayed 22 March 2019]. Available at https://www.ema.europa.eu/en/medicines/human/EPAR/epidyolex
- Electronic Medicines Compendium (EMC). Sativex Oromucosal Spray. SmPC, 2018 [displayed 22 March 2019]. Available at https://www.medicines.org.uk/emc/product/602/smpc
- Danish Medicines Agency. Medicinal use of Cannabis, 3rd ed. Copenhagen: Medicines Control & Inspection; 2015. File no.2013113424/ [displayed 22 March 2019]. Available at https://laegemiddelstyrelsen.dk/en/news/2015/updated-memo-on-medicinal-use-of-cannabis/~/media/CA79D52432AC4045A999C6C183FB173B.ashx
- Drugs.com Cesamet [displayed 22 February 2020]. Available at https://www.drugs.com/cesamet.html
- Álvares M. After legalisation, what next for medical cannabis in Portugal? Health Europa [displayed 30 January 2020]. Available at https://www.healtheuropa.eu/medical-cannabis-in-portugal/90986/
- Státní agentura pro konopí pro léčebné použití (SAKL). 236/2015 Coll. Decree of 4 September 2015 stipulating the conditions of prescribing, preparation, distribution, dispensing, and use of magistral formulas containing medical cannabis [cited 2019 May 5]. Available at http://www.sakl.cz/assets/user/Decree%20No%20236-2015.pdf
- Federal Institute for Drugs and Medical Devices. Annual Report 2017/2018. Bonn: Federal Institute for Drugs and Medical Devices, 2018 [displayed 22 March 2019]. Available at https://www.bfarm.de/SharedDocs/Downloads/EN/BfArM/Publikationen/AnnualReport2017-18.pdf?__blob=publicationFile&v=4
- Office of Medicinal Cannabis. Medicinal cannabis. The Hague: Institute for Responsible Medicine Use and the Office of Medicinal Cannabis of the CIBG, 2011 [displayed 22 March 2019]. Available at https://english.cannabisbureau.nl/medicinal-cannabis
- Regulation (EU) 2015/2283 of the European Parliament and of the Council of 25 November 2015 on novel foods, amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and repealing Regulation (EC) No 258/97 of the European Parliament and of the Council and Commission Regulation (EC) No 1852/2001 [displayed 22 March 2019]. Available at https://eur-lex.europa.eu/eli/reg/2015/2283/oj
- Deutscher Arzenimittel-Codex Neues Rezeptur-Formularium. Cannabis [displayed 22 February 2020]. Available at https://dacnrf.pharmazeutische-zeitung.de/index.php?id=suchen
- Zakon o lekarniški dejavnosti [Pharmacy Practice Act, in Slovenian]. Uradni list RS, št. 85/16 [displayed 22 February 2020]. Available at http://www.pisrs.si/Pis.web/pregledPredpisa?id=ZAKO7375
- Čufar A. Regulatorni vidik predpisovanja kanabinoidov [Prescribing of cannabinoids – a regulatory view, in Slovenian]. Farm Vestn 2016;67:91-6.
- World Health Organization (WHO). WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants. Geneva: WHO; 2003 [displayed 22 March 2019]. Available at http://apps.who.int/medicinedocs/pdf/s4928e/s4928e.pdf
- European Medicines Agency. Guidelines on Good Agricultural and Collection Practices ( GACP) for starting materials of herbal origin, 2006 Feb. EMEA/ HMPC/246816/2005 [displayed 22 March 2019]. Available at https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-agricultural-collection-practice-gacp-starting-materials-herbal-origin_en.pdf
- Malta Medicines Authority. General Guidelines on the Production of cannabis for medicinal and research purposes, 2018 Dec. Ref No: GL-CAN01/01 [displayed 22 March 2019]. Available at http://www.medicinesauthority.gov.mt
- Manifava D. Greece grants country’s first medical cannabis licenses, 2018 [displayed 22 March 2019]. Availble at http://www.ekathimerini.com/234842/article/ekathimerini/news/greece-grants-countrys-first-medical-cannabis-licenses
- Nanaimo B.C. Tilray® Increases International Export Capacity with New Outdoor Cultivation Site in Portugal, 2019 [displayed 22 March 2019]. Available at https://www.tilray.com/tilraynews-master/2019/8/7/tilray-increases-international-export-capacity-with-new-outdoor-cultivation-site-in-portugal
- Agency for Medicinal Products and Medical Devices of the Republic of Slovenia. Andreja Čufar. Stališče JAZMP v zvezi s predlogom o spremembi razvrstitve konoplje in ureditvi gojenja konoplje [JAZMP’s position on the proposal to amend the classification of cannabis and the regulation of cannabis cultivation, in Slovenian] [displayed 30 January 2020]. Available at https://www.jazmp.si/fileadmin/datoteke/dokumenti/Stalisce_JAZMP_glede_konoplje.pdf
- Publications Office of the EU. C/2017/4132 Common catalogue of varieties of agricultural plant species - fifth supplement to the 35th complete edition. Avilable at: https://op.europa.eu/en/publication-detail/-/publication/3d31e818-5715-11e7-a5ca-01aa75ed71a1
- European Commission. EU Novel food catalogue. Available at: http://ec.europa.eu/food/safety/novel_food/catalogue/search/public/?event=home&seqfce=72&ascii=